Indirect Evaluation of Bone Saturation With Zoledronic Acid After Long‐Term Dosing

Oncologist - United States
doi 10.1634/theoncologist.2018-0218
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Effects of Zoledronic Acid on Bone Fusion in Osteoporotic Patients After Lumbar Fusion

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2015English

Economic Evaluation of Denosumab Compared With Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients With Bone Metastases

Journal of Managed Care Pharmacy
2011English

Negative Impact of Zoledronic Acid in R-Chop Treated DLBCL With Bone Metastasis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Risk Factors Contributing to the Development of Hypocalcemia After Zoledronic Acid Administration in Patients With Bone Metastases of Solid Tumor

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2010English

A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year After Kidney Transplantation

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2019English

Zoledronic Acid and Skeletal Complications in Patients With Solid Tumors and Bone Metastases

Cancer
Cancer ResearchOncology
2008English

Intravitreal Hyaluronic Acid Injection. A Long-Term Clinical Evaluation.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1975English

TEP With Long-Term Resorbable Mesh in Patients With Indirect Inguinal Hernia

Journal of the Society of Laparoendoscopic Surgeons
Surgery
2018English

Long-Term Survival of Ex-Thalassemic Patients With Persistent Mixed Chimerism After Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy